Dipivefrin

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Dipivefrin
(IUPAC) ime
[2-(2,2-dimetilpropanoiloksi)-4- (1-hidroksi-2-metilamino-etil)- fenil] 2,2-dimetilpropanoat
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
MedlinePlus a686005
Identifikatori
CAS broj 52365-63-6
ATC kod S01EA02
PubChem[1][2] 3105
DrugBank DB00449
ChemSpider[3] 2994
UNII 8Q1PVL543G YesY
KEGG[4] D02349 YesY
ChEBI CHEBI:4646 YesY
ChEMBL[5] CHEMBL1201262 YesY
Hemijski podaci
Formula C19H29NO5 
Mol. masa 351,437 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća B(US)
Pravni status

Dipivefrin je prolek epinefrina koji se koristi za tretiranje glaukoma. On je dostupan kao oftalmički rastvor. Dipivefrin uzrokuje vazokonstrikciju, smanjuje proizvodnju očne tečnosti, i redukuje intraočni pritisak. On se konvertuje u epinefrin nakon penetracije korneje.[6]

Reference[uredi - уреди | uredi kôd]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0061%28200004%2917:1%3C48::AID-YEA2%3E3.0.CO;2-H/full. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Paul Diggory, Wendy Franks (1996). „Medical treatment of glaucoma - a reappraisal of the risks”. British Journal of Ophthalmology 80: 85-89. http://bjo.bmj.com/content/80/1/85. 

Spoljašnje veze[uredi - уреди | uredi kôd]